KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calix (CALX) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Calix (CALX) over the last 11 years, with Sep 2025 value amounting to $95.0 million.

  • Calix's Cash & Equivalents rose 52.36% to $95.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.0 million, marking a year-over-year increase of 52.36%. This contributed to the annual value of $43.2 million for FY2024, which is 31.93% down from last year.
  • Calix's Cash & Equivalents amounted to $95.0 million in Q3 2025, which was up 24.14% from $76.5 million recorded in Q2 2025.
  • Calix's Cash & Equivalents' 5-year high stood at $135.7 million during Q3 2023, with a 5-year trough of $42.3 million in Q1 2025.
  • Over the past 3 years, Calix's median Cash & Equivalents value was $84.5 million (recorded in 2024), while the average stood at $79.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 112.28% in 2023, then plummeted by 54.04% in 2024.
  • Quarterly analysis of 5 years shows Calix's Cash & Equivalents stood at $51.3 million in 2021, then surged by 54.04% to $79.1 million in 2022, then declined by 19.81% to $63.4 million in 2023, then slumped by 31.93% to $43.2 million in 2024, then spiked by 52.36% to $95.0 million in 2025.
  • Its Cash & Equivalents was $95.0 million in Q3 2025, compared to $76.5 million in Q2 2025 and $42.3 million in Q1 2025.